| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0194 |
610302-03-9 |
3-N-Boc-Aminocyclohexanol |
|
| A1-20312 |
1240584-68-2 |
(2S,5R)-1-N-Boc-2,5-Diethyl piperazine |
|
| A1-30000 |
177966-81-3 |
THYMOPENTIN |
|
| A1-30003 |
70458-95-6 |
Pefloxacin mesylate |
|
| A1-30008 |
66532-85-2 |
Propacetamol |
|
| A1-30010 |
526-18-1 |
2-Hydroxy-N-(4-hydroxyphenyl)-benzamide |
|
| A1-5260 |
875629-26-8 |
1-Methyl-3-Azetidinecarboxylic acid |
|
| A1-5479 |
N/A |
1-N-Boc-2(S)-Methyl-5(S)-ethyl piperazine |
|
| AS-1021 |
7226-23-5 |
1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone |
|
| AS-4412 |
50670-64-9 |
5-AMINO-2-METHYLBENZONITRILE |
|
| AS-8275 |
888216-25-9 |
Ganetespib |
|
| JR6-L3563 |
675840-13-8 |
2H-1-Benzopyran-2-one, 6-(acetyloxy)-3-(1,3-benzodioxol-5-yl)- |
|
| JR6-L3564 |
274693-27-5 |
Ticagrelor |
|
| JR6-L3565 |
55304-83-1 |
2,6-dibromonicotinaldehyde |
|
| JR6-L3579 |
17367-31-6 |
3-(Triphenylmethyloxy)-1-propanol |
|
| JR6-L3611 |
1450736-44-3 |
(3-((4-((4-(3-chlorophenyl)-5-(3,4-dimethylphenyl)pentyl)thio)benzyl)amino)propyl)phosphonic acid |
|
| JR6-L4021 |
345264-77-9 |
4H-Pyrrolo[3,2,1-ij]quinoline-6-methanol, 5,6-dihydro- |
|
| JR6-L5949 |
126912-70-7 |
1H-Pyrido[4,3-b]indole, 2,3,4,5-tetrahydro-8-methoxy- |
|
| JR6-L7374 |
1332591-57-7 |
4-Penten-2-ol, 1-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-4-methyl-, (2R)- |
|
| JR6-L7770 |
1280716-84-8 |
Benzeneacetic acid, a-amino-4-methoxy-a-(trifluoromethyl)-, methyl ester, (aR)- |
|
| JR6-L7782 |
1259948-21-4 |
L-Ornithine, 2-(trifluoromethyl)- |
|
| JR6-L7982 |
1344411-69-3 |
1H-Indole-3-carboxylic acid, 3-amino-7-chloro-2,3-dihydro-2-oxo-, (3R)- |
|
| JR6-L7993 |
1344478-41-6 |
1H-Indole-3-carboxylic acid, 3-amino-2,3-dihydro-7-nitro-2-oxo-, (3S)- |
|
| JR6-L9388 |
29504-81-2 |
2-Bromo-5-iodothiophene |
|
| JR6-L9389 |
23850-78-4 |
2-(2-methylpropyl)oxirane |
|
| JR6-L9390 |
1805551-65-8 |
6-Bromo-4-Pyrimidinemethanol |
|
| JR6-L9393 |
18289-89-9 |
(R)-METHYL 2,3-DIHYDROXYPROPANOATE |
|
| JR8-N0354 |
110623-72-8 |
Epimedin A |
|
|
|
|
|
|
|
|
|
|
|
|
|